Indication Investigational Compound Clinical Phase Status CTRI Clinicaltrials.gov
Idiopathic Pulmonary Fibrosis (Autologous) ADSC Phase-I/II Recruitment to commence Approved by DCGI -
Critical Limb Ischemia (Autologous) ADSC Phase-I/II Recruitment to commence Approved by DCGI -
Idiopathic Pulmonary Fibrosis (Allogeneic) ADSC Phase-I/II - Submitted to DCGI -
Type I Diabetes (Allogeneic) ADSC Phase-I/II - Submitted to DCGI -
A prospective, Multicentric, Phase 1, Open Label, Randomized, Interventional Study To Evaluate The Safety And Efficacy Of Intravenous Autologous Adipose Derived Adult Stem Cells For Treatment Of Idiopathic Pulmonary Fibrosis (IPF)

A prospective, Multicentric, Phase 1, Open Lable, Randomized, Interventional Study To Evaluate The Safety And Efficacy Of Autologous Adipose Derived Adult Stem Cells For Treatment Of Critical Limb Ischemia (CLI)

A Prospective, Multi-Centre, Randomized, Double Blind, Placebo Controlled, Bio Interventional, Phase I/II Study To Evaluate Safety And Efficacy Of Adipose Derived Allogeneic Mesenchymal Stem Cells For The Treatment Of Idiopathic Pulmonary Fibrosis (IPF).

A Prospective, Multi-Center, Randomized, Double Blind, Placebo Controlled Bio Interventional, Phase I/II Study To Evaluate Safety And Efficacy Of Adipose Derived Allogeneic Mesenchymal Stem Cells For The Treatment Of Type I Diabetes Mellitus (T1DM).